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Abstract: The co-occurrence of various cyanobacterial toxins can potentially induce toxic effects
different than those observed for single cyanotoxins, as interaction phenomena cannot be discarded.
Moreover, mixtures are a more probable exposure scenario. However, toxicological information on
the topic is still scarce. Taking into account the important role of mutagenicity and genotoxicity
in the risk evaluation framework, the objective of this study was to assess the mutagenic and
genotoxic potential of mixtures of two of the most relevant cyanotoxins, Microcystin-LR (MC-LR) and
Cylindrospermopsin (CYN), using the battery of in vitro tests recommended by the European Food
Safety Authority (EFSA) for food contaminants. Mixtures of 1:10 CYN/MC-LR (CYN concentration
in the range 0.04–2.5 µg/mL) were used to perform the bacterial reverse-mutation assay (Ames test)
in Salmonella typhimurium, the mammalian cell micronucleus (MN) test and the mouse lymphoma
thymidine-kinase assay (MLA) on L5178YTk± cells, while Caco-2 cells were used for the standard
and enzyme-modified comet assays. The exposure periods ranged between 4 and 72 h depending
on the assay. The genotoxicity of the mixture was observed only in the MN test with S9 metabolic
fraction, similar to the results previously reported for CYN individually. These results indicate
that cyanobacterial mixtures require a specific (geno)toxicity evaluation as their effects cannot be
extrapolated from those of the individual cyanotoxins.
Keywords: genotoxicity; mutagenicity; Cylindrospermopsin; Microcystin-LR; mixture
Key Contribution: A genotoxic and mutagenic assessment of cyanotoxin binary mixtures of CYN
and MC-LR was performed by a battery of in vitro tests. Results showed a similar response to CYN
individually. Thus, evaluation of mixtures is required as interactions can occur.
1. Introduction
Nowadays, a proliferation of cyanobacterial species can be seen globally because of water
eutrophication and climate change, leading to an increasing occurrence of cyanotoxins [1–3].
Cyanotoxins are toxic secondary metabolites produced by various species of cyanobacteria, which
involved an ample variety of compounds with different structural and physicochemical properties [4].
Humans may be exposed to cyanotoxins via different routes, but oral exposure by means of contaminated
water and foods (fish, crops, vegetables and food supplements) is by far the most important [5,6].
Microcystins (MCs) and cylindrospermopsins (CYN) are among the most frequently investigated
cyanotoxins due to their toxicity and extensive distribution.
MCs are cyclic heptapeptides and 246 variants were identified so far [7], with Microcystin-LR
(MC-LR) as the reference congener. The liver is the main target organ in MC-LR toxicity because of
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its uptake into hepatocytes by the organic anion transport system [8]. MC-LR inhibits the protein
serine/threonine phosphatases by covalent binding, especially PP1 and PP2. Thus, the proteins are
hyperphosphorylated leading to the modification of cytoskeleton and disruption of actin filaments [9].
In addition, MCs induce oxidative stress [1,10], disrupt different enzymatic activities [11,12] and induce
apoptosis [13]. MC-LR was classified as possible human carcinogen (Group 2B) by the International
Agency of Research on Cancer (IARC) [14]. It can produce genotoxic effects in vitro and in vivo [15],
although the mechanisms involved are not yet completely understood [16].
Cylindrospermopsins are guanidine alkaloid hepatotoxins with five known analogues [17].
Cylindrospermopsin (CYN) has zwitterionic characteristics, thus being highly water soluble and
chemically stable at high temperatures and a wide range of pH [18,19]. For these reasons, humans can
be more likely exposed to CYN than to other cyanotoxins as up to 90% of total CYN is presented in
surrounding waters. Although the liver and kidney are target organs of CYN, other organs such us
lungs, heart, thymus, stomach, spleen, intestinal tract, skin, nervous, immune, vascular and lymphatic
systems could also be damaged [1,20–22].
The absorption mechanism of CYN is not totally elucidated, but it was shown that paracellular
transport is involved in the intestinal uptake [1,23]. The main mechanisms of CYN toxicity is the
irreversible inhibition of protein synthesis [24,25] and glutathione (GSH) depletion [26] related to
the oxidative stress induced by CYN [27–29]. Moreover, the bioactivation of CYN by cytochrome
P-450 plays an important role in its mechanism of toxicity [30]. CYN was shown to induce DNA
fragmentation and DNA strands breaks [31–38]. However, it was not yet classified by its carcinogenic
potential by the IARC.
Both cyanotoxins have been extensively studied individually, but there are very few studies that
evaluate their combined effects, as indicated by the European Food Safety Authority (EFSA) [5]. The
simultaneous occurrence of MCs and CYN was reported repeatedly [39,40]. They have different chemical
structures and mechanisms of action, thus interaction phenomena such as synergism, antagonism or
toxicity potentiation must be considered. Moreover, a risk assessment can be greatly influenced when
diverging from individual toxin exposure to a multi-toxin exposure scenario. Gutiérrez-Praena et al. [41]
found an antagonistic effect of CYN and MC-LR when investigating the cytotoxicity of binary mixtures
in comparison to the individual toxins in HepG2 cells. Hercog et al. [42] observed a genotoxic potential
of CYN/MC-LR mixtures comparable to that of CYN alone when using the micronucleus (MN) and
comet assays in the same experimental model.
The exploration of the genotoxic potential of CYN/MC-LR applicable to food and feed safety
assessment is of great current interest. EFSA has indicated the need for further data on the toxicity of
cyanotoxins mixtures [5] following recommended genotoxicity testing strategies [43].
Thus, the purpose of this research was to assess the mutagenic and genotoxic potential of the
CYN/MC-LR mixtures trough a complete battery of different in vitro tests. This battery included:
(1) The bacterial reverse-mutation assay in five strains of Salmonella typhimurium (Ames test, OECD
471 [44]) which detects gene mutations in the absence and presence of the microsomal fraction S9;
(2) the Micronucleus test (MN, OECD 487 [45]) on L5178Y Tk+/− cells that detects clastogenic and
aneugenic chromosome aberrations in the absence and presence of the microsomal fraction S9; (3) the
standard and enzyme modified comet assays with restriction enzymes (Endonuclease III (Endo III) and
Formamide pyrimidine glycosylase (FPG)) that detect DNA strand breaks and oxidative DNA damage
in Caco-2 cells; (4) the mouse lymphoma thymidine-kinase assay (MLA, OECD 490 [46]) on L5178Y
Tk+/− cells to detect gene mutations in the timidine kinase (Tk) locus in the absence and presence of
the microsomal fraction S9. The microsomal fraction S9 was used to assess if CYN/MC-LR genotoxicity
is due to metabolic bioactivation of these toxins or due to the parent compounds.
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2. Results
2.1. Ames Test
No signals of toxicity and/or test solutions instability were observed during the test performance.
CYN/MC-LR mixtures did not induce changes in any of the S. typhimurium strains without S9 fraction
(Table 1). On the contrary, a significant increase in the number of revertants per plate was observed
with TA97A, TA102 and TA135 strains. However, a MI higher than 2 was not obtained in any of the
assayed experimental conditions. Solvent controls (MetOH 2% and DMSO) did not induce statistical
significant changes versus the negative controls.
2.2. Micronucleus Test
In the absence of S9 fraction, CYN/MC-LR mixtures did not increase the number of binucleated
cells with MN in any of the concentration assayed (Table 2). However, a significant reduction of the
cytokinesis-block proliferation index (CBPI) was observed at the highest concentration (1.35 µg/mL
CYN + 13.5 µg/mL MC-LR). Positive controls for clastogens (MMC) and aneugens (colchicine) showed
a significant increase in the frequency of binucleated cells with micronuclei (BNMN) (p < 0.01).
In the presence of S9 fraction, CYN/MC-LR induced an increase of BNMN (%) when compared
to the negative control, but only at 1 µg/mL CYN + 10 µg/mL MC-LR this change was statistically
significant (p < 0.01).
2.3. Mouse Lymphoma Thymidine-Kinase Assay (MLA)
Results of the MLA are shown in Tables 3–5. None of the evaluated CYN/MC-LR mixture
concentrations induced a mutagenic response in the absence or presence of S9 fraction, neither after a
short treatment (4 h) nor a long treatment (24 h). Concurrent vehicle control did not show changes in
comparison to negative control (data not shown).
2.4. Standard and Enzyme-Modified Comet Assays
Caco-2 cells exposure to CYN/MC-LR mixtures did not result in DNA strand breaks in the standard
comet assay after 24 and 48 h (Figure 1a). In addition, an oxidative damage induced genotoxicity was
not observed as the experiments performed with Endo III and FPG enzymes did not show a significant
increase of % DNA in tail (Figure 1b,c). Results for the solvent control were similar to the negative
control (data not shown) and only positive controls showed a significant (p < 0.001) genotoxicity.
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Table 1. Effect of CYN-MC-LR mixtures on the Ames test in three independent experiments by triplicate. Data are given as mean ± SD revertants/plate. * p < 0.05.
** p < 0.01 in comparison to negative control.
Concentration (µg/mL)
TA97A TA98 TA100 TA102 TA1535
−S9 MI +S9 MI −S9 MI +S9 MI −S9 MI +S9 MI −S9 MI +S9 MI −S9 MI +S9 MI
Pure
CYN-MC-LR
mixture
Negative
controls 231 ± 42 - 244 ± 5 - 21 ± 2 - 24 ± 9 - 117 ± 25 - 135 ± 14 - 215 ± 12 - 292 ± 11 - 293 ± 23 - 273 ± 33 -
0.125–1.25 297 ± 37 1.4 319 ± 51 1.3 19 ± 2 0.9 18 ± 8 0.8 136 ± 40 1.2 153 ± 21 1.1 230 ± 36 1.1 440 ± 29 ** 1.5 327 ± 25 1.1 376 ± 54 * 1.3
0.25–2.5 165 ± 28 0.8 334 ± 49 ** 1.4 20 ± 1 1.0 17 ± 7 0.7 144 ± 12 1.2 166 ± 24 1.2 217 ± 29 1.0 380 ± 33 ** 1.3 311 ± 10 1.1 411 ± 54 ** 1.4
0.5–5 213 ± 15 1.0 290 ± 58 1.2 26 ± 9 1.3 20 ± 10 0.9 154 ± 13 1.3 143 ± 19 1.1 251 ± 17 1.2 296 ± 18 10. 309 ± 42 1.1 336 ± 18 * 1.1
1–10 168 ± 10 0.8 234 ± 43 1.0 21 ± 2 1.0 19 ± 9 1.0 146 ± 18 1.2 130 ± 10 1.0 134 ± 12 0.6 383 ± 44 ** 1.3 250 ± 43 0.9 464 ± 44 ** 1.6
2–20 205 ± 31 1.0 295 ± 25 1.2 19 ± 5 0.9 25 ± 8 1.0 104 ± 31 0.9 143 ± 19 1.1 151 ± 1 0.7 397 ± 32 ** 1.4 276 ± 15 0.9 476 ± 52 ** 1.6
Positive
controls 613 ± 66 ** 2.9 527 ± 19 ** 2.2 883 ± 55 ** 42.0 960 ± 53 ** 40.9 816 ± 11 ** 7.0 583 ± 39 ** 4.3 950 ± 118 ** 4.4 671 ± 22 ** 2.3 833 ± 25 ** 2.8 659 ± 39 ** 2.2
MeOH 2% 176 ± 25 0.8 316 ± 32 1.3 17 ± 5 0.8 25 ± 13 1.1 92 ± 13 0.8 87 ± 29 0.6 192 ± 8 0.8 280 ± 12 0.6 313 ± 9 1.1 233 ± 35 0.9
DMSO 209 ± 66 1.3 184 ± 38 0.8 25 ± 2 1.2 30 ± 6 1.3 115 ± 5 1.0 113 ± 17 0.8 250 ± 65 1.2 231 ± 35 0.8 342 ± 63 1.2 298 ± 16 1.1
Negative control: Milli Q water. Control solvent: MeOH 2% and DMSO. Positive controls without S9 for TA97A: 9-aminoacridine (50 µg/plate), TA98: 2-nitrofluorene (0.1 µg/plate), TA100
and TA1535: NaN3 (1.5 µg/plate) and TA102: mytomicin C (2.5 µg/plate). Positive control for all strains with S9: 2-aminofluorene (20 µg/plate).
Table 2. Percentage of binucleated cells with micronuclei (BNMN) and cytokinesis-block proliferation index (CBPI) in cultured mouse lymphoma cells L5178YTk+/−
exposed to CYN+MC-LR mixture (n = 3). The genotoxicity assay was performed in the absence and presence of the metabolic fraction S9. The values are expressed as
mean ± SD. ** p < 0.01, *** p < 0.001 in comparison to negative control group values.
Experimental
Group
Absence of S9 Presence of S9
Exposure
Time (h)
Concentrations
(µg/mL)
BNMN (%)
± SD CBPI ± SD
Exposure
Time (h)
Concentrations
(µg/mL)
BNMN (%)
± SD CBPI ± SD
Negative control 24 - 2.3 ± 0.5 1.9 ± 0.1 4 - 2.5 ± 1.0 1.8 ± 0.1
Positive control 24
Mitomycin C
0.0625 10.5 ± 4.1 *** 1.5 ± 0.1 *** 4 Cyclophosfamide
8
8.3 ± 1.9 ** 1.8 ± 0.1
Colchicine
0.0125 9.6 ± 1.7 *** 1.8 ± 0.0
CYN+MC-LR
24 0.084–0.84 1.8 ± 1.5 1.9 ± 0.0 4 0.125–1.25 4.8 ± 2.6 1.8 ± 0.1
24 0.168–1.68 2.3 ± 1.0 1.9 ± 0.0 4 0.250–2.5 4.0 ± 1.4 1.8 ± 0.1
24 0.336–3.36 2.5 ± 0.6 1.8 ± 0.0 4 0.5–5 5.8 ± 1.5 1.8 ± 0.1
24 0.672–6.72 1.3 ± 0.5 1.7 ± 0.1 4 1–10 8.8 ± 4.2 ** 1.8 ± 0.1
24 1.35–13.5 0.8 ± 1.0 1.3 ± 0.3 *** 4 2–20 4.8 ± 0.5 1.8 ± 0.1
Clastogen and aneugen positive controls: mitomicyn C (0.0625 µg/mL) and colchicine (0.0125 µg/mL), respectively.
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Table 3. Toxicity and mutagenicity of CYN/MC-LR in L5178YTk+/− cells after 4 h without S9 fraction by the mouse lymphoma thymidine-kinase assay (MLA) (n = 2).
a: Total mutant frequency divided into small/large (S/L) colony mutant frequencies. The induced mutant frequency (IMF) was determined according to the formula
IMF = MF-SMF, where MF is the test culture mutant frequency and SMF is the spontaneous mutant frequency. *** p < 0.001.
Concentration (µg/mL)
Relative Total Growth Percent Plating Efficiency Mutant Frequency (× 10−6) MF (S/L) a IMF (MF-SMF) (× 10−6)
Experiment 1 Experiment 2 Experiment 1 Experiment 2 Experiment 1 Experiment 2 Experiment 1 Experiment 2 Experiment 1 Experiment 2
0 100 100 91 124 107 152 51/56 33/41 - -
0.04 CYN-0.4 MC 77 90 98 98 126 143 95/48 86/57 56 70
0.08 CYN-0.8 MC 98 100 93 70 202 157 111/91 102/55 95 83
0.16 CYN-1.6 MC 82 86 102 82 71 162 44/27 100/62 −14.4 89
0.33 CYN-3.3 MC 64 72 98 91 165 150 84/81 80/70 58 76
0.67 CYN-6.7 MC 57 58 95 88 174 144 106/68 60/84 67 71
MMS (10 µg/mL) 46 70 69 82 728 *** 738 *** 407/321 424/314 621 664
Positive controls: methylmethanesulfonate, MMS 10 µg/mL without S9 fraction and cyclophosphamide, CP 3 µg/mL with S9 fraction.
Table 4. Toxicity and mutagenicity of CYN/MC-LR in L5178YTk+/− cells after 4 h with S9 fraction by the mouse lymphoma thymidine-kinase assay (MLA) (n = 2).
a: Total mutant frequency divided into small/large (S/L) colony mutant frequencies. The induced mutant frequency (IMF) was determined according to the formula
IMF = MF-SMF, where MF is the test culture mutant frequency and SMF is the spontaneous mutant frequency. *** p < 0.001.
Concentration (µg/mL)
Relative Total Growth Percent Plating Efficiency Mutant Frequency (× 10−6) MF (S/L) a IMF (MF-SMF) (× 10−6)
Experiment 1 Experiment 2 Experiment 1 Experiment 2 Experiment 1 Experiment 2 Experiment 1 Experiment 2 Experiment 1 Experiment 2
0 100 100 93 102 155 146 96/59 82/64 - -
0.04 CYN-0.4 MC 96 84 82 84 94 100 43/51 42/58 −61 −46
0.08 CYN-0.8 MC 82 72 91 91 95 95 50/45 50/45 −60 −51
0.16 CYN-1.6 MC 58 51 95 100 98 95 48/50 49/47 −57 −51
0.33 CYN-3.3 MC 58 56 102 100 98 105 56/43 60/45 −57 −41
0.67 CYN-6.7 MC 26 31 118 113 120 132 62/58 77/55 −35 −14
1.35 CYN-13.5 MC 16 16 130 116 70 91 29/41 38/53 −85 −55
CP (3 µg/mL) 99 81 65 73 480 *** 433 *** 228/252 213/220 325 286
Positive controls: methylmethanesulfonate, MMS 10 µg/mL without S9 fraction and cyclophosphamide, CP 3 µg/mL with S9 fraction.
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Table 5. Toxicity and mutagenicity of CYN/MC-LR in L5178YTk+/− cells after 24 h without S9 fraction by the mouse lymphoma thymidine-kinase assay (MLA) (n = 2).
a: Total mutant frequency divided into small/large (S/L) colony mutant frequencies. The induced mutant frequency (IMF) was determined according to the formula
IMF = MF-SMF, where MF is the test culture mutant frequency and SMF is the spontaneous mutant frequency. *** p < 0.001.
Concentration (µg/mL)
Relative Total Growth Percent Plating Efficiency Mutant Frequency (× 10−6) MF (S/L) a IMF (MF-SMF) (× 10−6)
Experiment 1 Experiment 2 Experiment 1 Experiment 2 Experiment 1 Experiment 2 Experiment 1 Experiment 2 Experiment 1 Experiment 2
0 100 100 113 124 170 170 106/72 87/92 - -
0.04 CYN-0.4 MC 103 115 90 87 107 78.9 62/45 48/30 −71 −100
0.08 CYN-0.8 MC 91 102 102 93 121 124 50/71 72/52 −57 −55
0.16 CYN-1.6 MC 79 96 76 108 143 100 81/66 56/44 −35 −79
0.33 CYN-3.3 MC 71 74 116 104 115 168 64/51 109/59 −63 −12
0.67 CYN-6.7 MC 39 39 127 104 113 195 74/39 77/118 −66 16
MMS (10 µg/mL) 52 66 35 34 778 *** 897 *** 370/408 459/438 599 718
Positive controls: methylmethanesulfonate, MMS 10 µg/mL without S9 fraction and cyclophosphamide, CP 3 µg/mL with S9 fraction.
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shown an antagonistic effect regarding cytotoxicity [41] and genotoxicity [42] in HepG2 cells. In 
addition, the genotoxicity of CYN/MC-LR mixtures has not been previously evaluated following a 
complete battery of in vitro tests, and a potential antagonic result for the mixture could affect the risk 
evaluation. 
The first assay included in the basic battery was the Ames test. The mixture did not show a 
mutagenic response at the conditions tested, similar to previous results obtained for CYN [35]. In 
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always lower than 2. As CYN concentrations were similar in both studies, the results obtained suggest 
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Figure 1. DNA damage in Caco-2 cells after exposure to CYN+MC-LR mixtures for 24 and 48 h. Results
expressed as the formation of strand breaks (a) and oxidative DNA damage as Endo III-sensitive sites
(b) and FPG-sensitive sites (c) (n = 3). The level of DNA strand-breaks (SBs), oxidized pyrimidines and
oxidized purines are expressed as % DNA in tail. All values are expressed as mean ± SD. Negative
control (C-): culture medium. Positive controls (C+): 100 µM H2O2 for the standard comet assay and
Endo III-sensitive sites, and 2 µM of Ro 19-8022 photosensitizer with light irradiation for FPG-sensitive
sites. *** p < 0.001.
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3. Discussion
The data on the genotoxicity of a chemical is of key importance as it drives the type of human risk
assessment to be performed. While a genotoxic chemical and health-based guidance value is usually
set, for an unavoidable chemical, that is, a genotoxic carcinogen, the Margin of Exposure approach is
usually applied [47]. For the generation and evaluation of data on genotoxic potential, the EFSA [43]
recommends a step-wise approach for the generation and evaluation of data on genotoxic potential that
begins with a basic battery of in vitro tests, including a bacterial reverse mutation assay and an in vitro
MN assay. Moreover, further in vitro assays should be conducted in case of inconclusive, conflicting
or equivocal results. The need for using several assays is justified as it is considered that there is no
single mutagenicity test which can detect all kinds of potential human mutagens with 100% accuracy
or prediction. This was shown to be true as mutagenesis itself is multifactorial [48].
Moreover, the genotoxicity evaluation of chemical mixtures is of great current interest and the
EFSA has recently published a statement on the topic [49]. Thus, the Scientific Committee advocates
for chemically fully defined mixtures, a component based approach, i.e., assessing all components
individually using all suitable information including read across and quantitative structure–activity
relationship (QSAR) considerations about their genotoxic potential, following the Scientific Committee
guidance already mentioned [43]. In the present case, there are available data on CYN genotoxicity
following EFSA recommendations [38], while MC-LR, was classified by the IARC in group 2B [14].
Moreover, the two single toxicity studies dealing with CYN/MC-LR mixtures have shown an antagonistic
effect regarding cytotoxicity [41] and genotoxicity [42] in HepG2 cells. In addition, the genotoxicity of
CYN/MC-LR mixtures has not been previously evaluated following a complete battery of in vitro tests,
and a potential antagonic result for the mixture could affect the risk evaluation.
The first assay included in the basic battery was the Ames test. The mixture did not show a
mutagenic response at the conditions tested, similar to previous results obtained for CYN [35]. In both
cases, TA102 was one of the most responsive strains although the mutagenic indexes (MI) was always
lower than 2. As CYN concentrations were similar in both studies, the results obtained suggest that
MC-LR does not contribute to the genotoxicity of the mixture. This agrees with Sieroslawska [50] who
found no effects in the Ames microplate format mutagenicity assay for pure MC-LR, pure CYN and
neither for a mixture CYN/MC-LR/Anatoxin-a (1 µg/mL each).
A MN test is included in the basic battery to cover potential structural and numerical chromosome
aberrations in addition to the Ames test. Chromosomal abnormalities, such as increased chromosomal
breakage or chromosomal loss, are associated with enhanced risk of carcinogenesis and progression
of neoplastic transformation [51]. In the case of the CYN/MC-LR mixture, an increase of MN was
only observed with S9 fraction, similar to CYN in an individual exposure [38]. Moreover, single
CYN showed this enhancement from lower concentrations (0.25 µg/mL) whereas the mixture showed
this effect at 1 µg/mL CYN (+10 µg/mL MC-LR). This finding suggests that MC-LR ameliorates in
this case the CYN response. However, in the scientific literature, there are contradictory data on the
genotoxic potential of MC-LR by the MN assay. Thus, Abramsson-Zetterberg et al. [52] did not observe
changes in vitro (in human lymphocytes, up to 2.0 mg extract of freeze-dried cyanobacteria per ml
cell culture) and in vivo (in mice up to 55 µg/kg bw pure MC-LR by i.p. administration). On the
contrary, Dias et al. [15] found that MC-LR treatment (5 and 20 µM) caused a significant induction in
the MN frequency in kidney- (Vero-E6) and liver-derived (HepG2) cell lines and, interestingly, a similar
positive effect was observed in mouse reticulocytes (37.5 µg MCLR/kg, i.p. route). Huang et al. [53]
found that MC-LR induced a 1.6-fold increase in MN frequency in a human–hamster hybrid AL cell
line after 30 days of exposure to 0.1 µg/mL (but no changes after 1 and 3 days of exposure). Regarding
cyanobacterial mixtures, there is a single study that explored the MN induction of a CYN/MC-LR
mixture and found that 0.5 µg/mL CYN + 1 µg/mL MC-LR induced a significant increase of MN in
HepG2 cells [42].
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Additional in vitro methods were applied (MLA and Comet assay), following the
recommendations of [43], because the results obtained with the Ames test and the MN assay did not
allow confirmation of the genotoxicity (or absence of genotoxicity) of the mixture.
The MLA results did not provide new evidence as no changes were observed at any of the
conditions tested. Puerto et al. [38] also did not find a mutagenic response when single CYN exposure
was evaluated. Zhan et al. [54] performed the TK gene mutation assay in the TK6 human lymphoblastoid
cell line for MC-LR and found TK mutation in a concentration-dependent manner. The MLA is the
most extensively used of the different in vitro mammalian gene-mutation assays [55]. Both MN assay
and MLA are performed in the same experimental model, the L5178YTk+/− cells, recommended in the
Organization for Economic Co-operation and Development OECD guidelines. It seems that MN assay
is more sensitive, or that the potential mutagenicity of the evaluated cyanotoxins is related mostly
with chromosomal aberrations and to a lesser extent, with gene (point) mutations. However, the MLA
detects intragenic events, mainly point mutations, and also loss of heterozygosity. This can result from
the entire Tk gene loss, leading to karyotypically visible deletions and rearrangements of the Tk+/−
bearing chromosome [56]. These features make the MLA especially useful to evaluate the ability of
chemicals to induce a broad variety of mutational events [57].
Similarly, the Comet assay also did not evidence DNA damage induced by the CYN/MC-LR mixture
in any of the procedures performed, that is, the standard assay and the modified version to detect
oxidative DNA-damage. CYN alone showed the same response in similar conditions: Experimental
model, concentrations and times of exposure [38]. Other authors, however, have observed genotoxic
effects for CYN in the Comet assay both in vitro [31,33,34] and in vivo [58,59]. MC-LR single exposure
was also reported to induce DNA strand breaks by the comet assay in vitro [15,60–62] and in vivo [15].
There is a single study [42] that showed DNA strand breaks induction by cyanobacterial mixtures
CYN/MC-LR in HepG2 cells after 24 h exposure, but to lesser degree than CYN. Once more, it seems
that MC-LR ameliorates the genotoxicity induced by CYN.
Overall, it is difficult to derive any statement about the (geno)toxicity of CYN/MC-LR mixtures
because the available studies in the scientific literature for the individual toxins mostly use different
model systems and exposure concentrations. This is the first time that a thorough investigation using 4
different mutagenicity and genotoxicity assays has been performed for cyanobacterial mixtures and
the results indicate that the mixture does not show a higher genotoxicity compared to CYN. However,
taking into account that MC-LR was classified in the group 2B by the IARC due to its tumour promotion
mechanism [14], caution is required when trying to elucidate its role in the mixture toxicity.
As Zouaoui et al. [63] highlighted, the type of interactions among toxins could be related with the
different chemical structures and properties, and the competition or not, for the same cell receptor.
It is, therefore, required to explore the cyanotoxins mechanisms of action when they are alone or in
mixtures. In this case, the investigated cyanotoxins showed different toxicity mechanisms but also
share others, such as the oxidative stress induction. Thus, Gutiérrez-Praena et al. [41] suggested that
the depletion of GSH could be related with the antagonistic response as it could decrease the uptake
ratio of CYN. Other authors such as Hercog et al. [42] pointed out to their different kinetics as MC-LR
and CYN are detoxified and toxified, respectively, after [30,64] and also to the compromise of DNA
repair mechanisms induced by MC-LR [65]. In any case, further studies would be required to fully
understand the mechanisms involved in the toxicity of mixtures. Moreover, despite using the battery
proposed by EFSA [43], considering the results obtained (positive effects only in one of the four tests
performed) and the limitations of in vitro genotoxicity tests to predict the in vivo situation suggested by
Nesslany [66], the further step would be to assess in vivo the genotoxicity of cyanobacterial mixtures.
4. Conclusions
The in vitro mutagenicity and genotoxicity showed by CYN/MC-LR mixtures do not differ
substantially from that observed for CYN tested individually. This effect was evident only when S9
fraction was used, indicating the relevance of CYN on the mixture toxicity at the conditions tested.
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The increased knowledge of cyanotoxins mixture genotoxic potential would contribute to perform
more realistic risk evaluations.
5. Materials and Methods
5.1. Chemicals and Reagents
Cylindrospermopsin (95% purity) and Microcystin-LR (99% purity) standards were provided by
Alexis Corporation (Lausen, Switzerland). Chemicals for different assays were supplied by Gibco
(Biomol, Sevilla, Spain), Sigma -Aldrich (Madrid, Spain), C-Viral S.L. (Sevilla, Spain) and Moltox
(Trinova, Biochem, Germany).
5.2. Cells and Culture Conditions
Five Salmonella typhimurium histidine-auxotrophic strains TA97A, TA98, TA100, TA102 and TA1535
were used for the Ames test. L5178Y Tk+/− mouse lymphoma cells used for the MN test and MLA
were originally provided by Dr. Oliver Gillardeux (Safoni-Synthélabo, Paris, France). Caco-2 cell line,
used for standard and enzyme-modified comet assays, come from a human colon adenocarcinoma
(ATCC© HTB-37). L5178Y Tk+/− cells and Caco-2 cells were maintained in an incubator with 5% CO2
and 95% relative humidity at 37 ◦C.
5.3. Test Solutions
Stock solution of CYN (1000 µg/mL) and MC-LR (4000 µg/mL) were prepared in milliQ sterile
water and water: MeOH, respectively and stored at less than 4 ◦C. The exposure concentration solutions
were prepared by dilution in sterile MilliQ water (Ames test), RPMI 1640 medium (MN and MLA
assays) or MEM medium (standard and enzyme-modified comet assays). Test concentrations were
selected individually for every test as they need to fulfil toxicity criteria in each of the experimental
models used. The selected concentrations of MC-LR were 10 times higher than that of CYN since
MC-LR is normally more abundant in nature [1,2,67].
5.4. Bacterial Reverse Mutation Test (Ames Test)
The Ames test was performed following the OECD Guideline 471 [44] and Maron et al. [68] with
minor modifications as follows. Five Salmonella typhimurium histidine-auxotrophic strains (TA97, TA98,
TA100, TA102 and TA1535) obtained from TRINOVA BIOCHEM GmbH (Germany) were cultured
following the provider instructions. The mutagenic activity of CYN/MC-LR mixtures was assessed in
the absence and presence of the external metabolic activation system from rat livers (S9 fraction). Each
experiment was conducted with five growing concentrations of CYN/MC-LR mixtures (0.125–2 µg/mL
CYN and 1.25–20 µg/mL MC-LR) selected according to the results obtained by Puerto et al. [38] when
CYN mutagenicity was assessed by the Ames test. Also, a negative control (distilled sterile water),
solvent controls (MeOH and DMSO) and a positive control for each strain in accordance with the
presence or absence of S9 fraction were included. Nine-aminoacridine (50 µg/plate) was the positive
control for TA97A without S9 fraction; 2-Nitrofluorene (2-NF) (0.1 µg/plate) for TA98; sodium azide
(NaN3) (1 µg/plate) for TA100 and TA1535; and mitomycin C (MMC) (2.5 µg/plate) for TA102. The
positive control in the presence of S9 fraction was 2-aminofluorene (2-AF) (20 µg/plate) for all strains.
At least 3 independent experiments were performed using triplicate plates for each test concentration.
Results are expressed as revertant colonies and mutagenic indexes (MI).
5.5. Micronucleus Test (MN)
The MN test was carried out following the OECD guideline 487 [45]. L5178Y Tk+/− cells were
seeded at a density of 2.0 × 105 cell/mL and exposed to five different concentrations of CYN/MC-LR
mixture (0.084–1.35 µg/mL CYN and 0.84–13.5 µg/mL MC-LR in the absence of S9 fraction for 24 h,
and 0.125–2 µg/mL CYN and 1.25–20 µg/mL MC-LR for 4 h in the presence of S9 fraction). These
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concentrations were selected taking into account previous results obtained in cytotoxicity assays and
carried out according to the OECD Guideline 487 [45]. The RPMI medium was used as negative
control; MeOH as vehicle control; and 0.0625 µg/mL MMC and 0.0125 colchicine (without S9 fraction)
and 8 µg/mL cyclophosphamide (CP) (with S9 fraction) as positive controls. Cells were exposed to
CYN/MC-LR mixtures (4 or 24 h, with and without S9 mix, respectively), then exposed to cythochalasin
B (Cyt-B) (6 µg/mL) for 20 h to block cytokinesis and obtain binucleated cells. Afterward, cells were
exposed to a hypotonic treatment with KCl and fixed. Subsequently, cells were dripped on slides
and stained with Giemsa 10%. Quantification of binucleated cells with micronuclei (BNMN) and
cytokinesis-block proliferation index (CBPI) were carried out following the OECD 487 guideline [45]
by analysing at least 2000 binucleated cells/concentration.
5.6. Mouse Lymphoma Thymidine-Kinase Assay (MLA)
The MLA assay was performed in agreement to OECD Guideline 490 [46] and Maisanaba et al. [69].
Each experiment includes a negative control (fresh media), a solvent control (MeOH), a positive control
(methylmetanosulfonate, MMS 10 µg/mL in absence of S9 fraction and cyclophosphamide, CP 3 µg/mL
in presence of S9 fraction), five concentrations of CYN/MC-LR mixture in the absence of S9 fraction
for 4 and 24 h assays (0.04–0.67 µg/mL CYN and 0.4–6.7 µg/mL MC-LR) and six concentrations in
the presence of S9 fraction for 4 h assay (0.04–1.35 µg/mL CYN and 0.4–13.5 µg/mL MC-LR). These
concentrations were selected in accordance with previous tests performed to define the cytotoxicity
of CYN/MC-LR mixtures by the relative total growth (RTG) after 4 and 24 h of treatment without
S9 fraction. According to the ICH Expert Working Group [70], the highest concentration chosen for
the mutagenicity test must be higher than 10–20% of RTG. RTG values were employed to determine
the acceptability of the toxicity at each concentration. Cells were seeded at 104 cells/mL in 96-well
plates (two replicates per experimental group) to assess the viability and mutagenicity. The mutation
analysis cells were exposed to 4 µg/mL trifluorothymidine (TFT), and both the viability plates and the
mutagenicity plates were incubated at 37 ◦C and 5% CO2 for 12 days. Afterwards, viable colonies and
TFT mutation colonies were counted. Thiazolyl blue tetrazolium (MTT) (2.5 mg/mL) was added to
wells to facilitate the counting of mutant colonies, and the plates were incubated for 4 h. According to
Honma et al. [71], the size of the colonies were described as small (less than 1/3 of well diameter) or
large (higher than 1/3 of well diameter) colonies. Moreover, the induced mutant frequency (IMF) was
also analyzed.
5.7. Standard and Enzyme-Modified Comet Assay
The standard comet assay was carried out to evaluate genotoxicity, and a modified version of this
assay with endonuclease III (Endo III) and formamidopyrimidine (FPG), which recognise oxidized
pyrimidines and purines, was performed to determine oxidative DNA damage, respectively.
The standard and enzyme-modified comet assays were carried out to assess the genotoxicity of
CYN/MC-LR mixtures, as previously described by Collins et al. [72] and Llana-Ruiz-Cabello et al. [73].
Caco-2 cell line was selected as cyanotoxins are food contaminants and it is a commonly used enterocytic
model in toxicological studies [74–77]. Cells were seeded at 3.5 × 105 cells/mL into 24-well tissue
culture plates and treated with increasing concentrations of CYN/MC-LR mixtures (0.6–2.5 µg/mL
CYN and 6–25 µg/mL MC-LR) for 24 h and 48 h, according to the value obtained in the most sensitive
cytotoxicity endpoint assayed [76]. Cells were treated with a negative control (medium) and a positive
control (H2O2 100 µM) for standard comet assay and Endo III sensitives sites and Ro 19-8022 (2 µM)
for FPG-sensitive sites. After exposure time, cells were washed, trypsinized and re-suspended in
phosphate buffer saline (PBS) at 2.5 × 105 cell/mL. Cells suspensions were mixed with 1% (w/v)
low-melting-agarose in PBS and placed on agarose precoated glass slides. Afterwards, lysis, incubation
with Endo III and FPG (in the case of modified comet assay), denaturing, electrophoresis, neutralization,
washing, fixation, dying, staining with SYBR Gold and quantification of nuclei were performed.
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Olympus BX61 (fluorescence microscope) with the comet assay IV software (Perceptive Instruments,
UK) available at the Microscopy Service of the University of Seville (CITIUS) was used to score the
cells. The results were expressed as mean % DNA in tail respect to the negative control group. The
% DNA in tail represents the amount of DNA breakage. Both types of comet assays (standard and
modified) were performed in at least three independent experiments and using a triplicate/experiment.
5.8. Statistical Analysis
The statistical analysis was performed with Graph-Pad InStat software (Graph-Pad Software Inc.,
La Jolla, CA, USA). The non-parametric Wilcoxon matched-pairs signed-rank test was employed to
compare the exposed samples with the negative control. Differences were considered significant at
* p < 0.05, ** p < 0.01 and *** p < 0.001, respectively.
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